amikacin has been researched along with deoxyguanosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bal, W; Ciesiołka, J; Jezowska-Bojczuk, M; Leśniak, W; Szczepanik, W; Wrzesiński, J | 1 |
Alp, HH; Ari, E; Basbugan, Y; Bayram, I; Bektas, H; Bulut, G; Erten, R | 1 |
2 other study(ies) available for amikacin and deoxyguanosine
Article | Year |
---|---|
DNA and RNA damage by Cu(II)-amikacin complex.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Amikacin; Base Sequence; Copper; Deoxyguanosine; DNA Damage; Electrophoresis, Agar Gel; Hydrogen Peroxide; Hydrogen-Ion Concentration; Kinetics; Mass Spectrometry; Models, Chemical; Molecular Sequence Data; Nucleic Acid Conformation; Oxygen; Plasmids; RNA; RNA, Transfer, Amino Acyl; Saccharomyces cerevisiae; Spectrometry, Mass, Electrospray Ionization; Time Factors | 2002 |
Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Amikacin; Animals; Anti-Bacterial Agents; Bone Density Conservation Agents; Deoxyguanosine; Disease Models, Animal; DNA Damage; Ergocalciferols; Kidney; Kidney Diseases; Kidney Function Tests; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A | 2016 |